These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18086943)

  • 1. Mineralocorticoid signaling in transition to heart failure with normal ejection fraction.
    Shapiro BP; Owan TE; Mohammed S; Kruger M; Linke WA; Burnett JC; Redfield MM
    Hypertension; 2008 Feb; 51(2):289-95. PubMed ID: 18086943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model.
    Shapiro BP; Lam CS; Patel JB; Mohammed SF; Kruger M; Meyer DM; Linke WA; Redfield MM
    Hypertension; 2007 Sep; 50(3):503-11. PubMed ID: 17620524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".
    Mohammed SF; Ohtani T; Korinek J; Lam CS; Larsen K; Simari RD; Valencik ML; Burnett JC; Redfield MM
    Circulation; 2010 Jul; 122(4):370-8. PubMed ID: 20625113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction.
    Methawasin M; Strom JG; Slater RE; Fernandez V; Saripalli C; Granzier H
    Circulation; 2016 Oct; 134(15):1085-1099. PubMed ID: 27630136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failure.
    Munagala VK; Hart CY; Burnett JC; Meyer DM; Redfield MM
    Circulation; 2005 Mar; 111(9):1128-35. PubMed ID: 15723971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
    Schwarzl M; Hamdani N; Seiler S; Alogna A; Manninger M; Reilly S; Zirngast B; Kirsch A; Steendijk P; Verderber J; Zweiker D; Eller P; Höfler G; Schauer S; Eller K; Maechler H; Pieske BM; Linke WA; Casadei B; Post H
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1407-18. PubMed ID: 26342070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines.
    Shapiro BP; Owan TE; Mohammed SF; Meyer DM; Mills LD; Schalkwijk CG; Redfield MM
    Circulation; 2008 Sep; 118(10):1002-10. PubMed ID: 18711013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arterial vasodilatory and ventricular diastolic reserves determine the stroke volume response to exercise in elderly female hypertensive patients.
    Sahlén A; Abdula G; Norman M; Manouras A; Brodin LÅ; Lund LH; Shahgaldi K; Winter R
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2433-41. PubMed ID: 21926340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left Atrial Remodeling and Atrioventricular Coupling in a Canine Model of Early Heart Failure With Preserved Ejection Fraction.
    Zakeri R; Moulay G; Chai Q; Ogut O; Hussain S; Takahama H; Lu T; Wang XL; Linke WA; Lee HC; Redfield MM
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
    Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L
    J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real time 3D echocardiography (RT3D) for assessment of ventricular and vascular function in hypertensive and heart failure patients.
    Scali MC; Basso M; Gandolfo A; Bombardini T; Bellotti P; Sicari R
    Cardiovasc Ultrasound; 2012 Jun; 10():27. PubMed ID: 22742054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L; Ooi SY; Lau K; Sernia C
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction.
    Costello-Boerrigter LC; Boerrigter G; Harty GJ; Cataliotti A; Redfield MM; Burnett JC
    Hypertension; 2007 Sep; 50(3):481-8. PubMed ID: 17635858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
    Chan V; Hoey A; Brown L
    Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
    Minatoguchi S; Kawasaki M; Tanaka R; Yoshizane T; Ono K; Saeki M; Nagaya M; Sato H; Nishigaki K; Noda T; Zile MR; Minatoguchi S
    Heart Vessels; 2017 Oct; 32(10):1202-1213. PubMed ID: 28638961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations.
    Kawaguchi M; Hay I; Fetics B; Kass DA
    Circulation; 2003 Feb; 107(5):714-20. PubMed ID: 12578874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
    Rothermund L; Vetter R; Dieterich M; Kossmehl P; Gögebakan O; Yagil C; Yagil Y; Kreutz R
    Circulation; 2002 Oct; 106(18):2305-8. PubMed ID: 12403658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction.
    Hieda M; Sarma S; Hearon CM; Dias KA; Martinez J; Samels M; Everding B; Palmer D; Livingston S; Morris M; Howden E; Levine BD
    Circulation; 2020 Jan; 141(2):115-123. PubMed ID: 31865771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-related differences in left ventricular diastolic function and arterial elastance during admission in patients with heart failure with preserved ejection fraction: The PURSUIT HFpEF study.
    Hoshida S; Watanabe T; Shinoda Y; Ikeoka K; Minamisaka T; Fukuoka H; Inui H; Ueno K; Suna S; Nakatani D; Hikoso S; Yamada T; Yasumura Y; Fuji H; Sakata Y;
    Clin Cardiol; 2018 Dec; 41(12):1529-1536. PubMed ID: 30225990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Sympathetic Denervation in Patients With Heart Failure With Preserved Ejection Fraction.
    Kresoja KP; Rommel KP; Fengler K; von Roeder M; Besler C; Lücke C; Gutberlet M; Desch S; Thiele H; Böhm M; Lurz P
    Circ Heart Fail; 2021 Mar; 14(3):e007421. PubMed ID: 33706547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.